← Back

$ Value

$0

Shares

8,769

Price

$0

Filed

Jul 17

Insider

Name

Issa Mohamed Khairie

Title

EVP, Head of US Oncology

CIK

0002050035

Roles

Officer

Transaction Details

Transaction Date

2025-07-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

85,252

Footnotes

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the July 15, 2025 grant, this includes an aggregate of 85,252 shares of common stock issuable pursuant to previously reported RSUs that have not vested. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. | The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Filing Info

Accession No.

0000879169-25-000090

Form Type

4

Issuer CIK

0000879169

Issa Mohamed Khairie's History

Date Ticker Type Value
2025-07-15 INCY A $0
2025-07-15 INCY A $0
2025-07-15 INCY A $0
2025-06-30 INCY A $0

Other Insiders at INCY (90d)

Insider Bought Sold Last
HARRIGAN EDMUND 2026-03-31
CAGNONI PABLO J
President, Global Head of R&D
$1.8M 2026-04-17
BAKER BROS. ADVISORS LP 2026-03-31
Clancy Paul J 2026-03-31
Meury William
Chief Executive Officer
2026-04-15
Stein Steven H
CMO & Head of Late-Stage Dev.
2026-04-15
Trotta Matteo
EVP, GM, Dermatology US
2026-03-25